Podcasts about serm

En Ahora o Nunca, la mesa reacciona a la conquista de una Copa Oro más de México tras vencer a Estados Unidos en la Final y cuestiona si este nuevo titulo hace al Tri el favorito para ser el mejor equipo de la Concacaf en el Mundial 2026. En el Mundial de Clubes, las Semifinales están listas y aunque el Fluminense y el Chelsea abren las acciones, la mesa centra su análisis en el duelo entre un PSG que está en Modo Competitivo al final de su temporada y un Real Madrid que apenas comienza a calentar motores para su próxima campaña en una pretemporada competitiva. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Sermón: Proverbio 15:1-31 Serie: Verano en Los Proverbios Pastor Felix Colón

====================================================SUSCRIBETEhttps://www.youtube.com/channel/UCNpffyr-7_zP1x1lS89ByaQ?sub_confirmation=1==================================================== DEVOCIÓN MATUTINA PARA JÓVENES 2025“HOY ES TENDENCIA”Narrado por: Daniel RamosDesde: Connecticut, USAUna cortesía de DR'Ministries y Canaan Seventh-Day Adventist Church===================|| www.drministries.org ||===================08 de JulioEl efecto Messi«Ustedes son la sal de este mundo». Mateo 5: 13Aunque no soy un experto en fútbol, en julio de 2023 me llené de alegría al enterarme de que Lionel Messi, considerado el mejor jugador del mundo, había aceptado la oferta para unirse al equipo de mi ciudad, el Inter de Miami. La noticia desató una ola de entusiasmo en toda la ciudad: los memes inundaron las redes sociales y las camisetas de Messi se agotaron rápidamente. Pero el impacto más significativo se observó en el campo de juego. Desde su llegada, el Inter experimentó una racha impresionante de doce victorias consecutivas. Incluso cuando el astro no está en el campo, se percibe que los demás jugadores juegan con mayor confianza y logran un rendimiento destacado.En el Sermón del Monte, Jesús comparó a sus seguidores con la sal y la luz (ver Mateo 5: 13-14). Esta metáfora ilustra el impacto que Dios nos llama a tener en el mundo y cómo nuestra presencia en él debe contribuir a hacerlo un lugar mejor. No es necesario ocupar una posición de liderazgo para ejercer un impacto positivo; no hace falta ser un «Messi» para ser la sal de este mundo.La Biblia contiene muchas historias sobre cómo los hijos de Dios somos una bendición en cualquier lugar que nos encontremos. José, Daniel, Ester y la sierva de Naamán fueron una bendición para otros, incluso a pesar de ser esclavos en un país extraño. Cuando vivimos de acuerdo con los principios de amor, bondad y justicia que Jesús nos enseñó, nuestra influencia no tiene límites.Es interesante observar cómo el Inter de Miami muestra un mejor desempeño incluso en ausencia de Messi. ¿No crees que eso constituye una buena meta para los cristianos? Es inspirador ser una influencia tan poderosa en el mundo que, incluso cuando no estamos presentes físicamente, contribuimos a que los demás se conviertan en mejores personas. Elena G. de White escribió que «cada uno ejerce una influencia para bien o para mal».* Hoy tú tienes en tus manos el poder de cambiar tu entorno, de ser sal y luz. ¿Decides hoy influir positivamente en tu entorno siendo la sal y la luz del mundo? 

¿Y si el amor propio no fuera una emoción, sino una decisión? En este episodio te explico por qué quererte NO empieza cuando te sientes bien contigo, sino cuando eliges actuar desde el respeto, incluso en medio del miedo o la duda. Aprende a dejar de odiarte y a construir una relación contigo que se base en acción, coherencia y dignidad. ⭐ Accede GRATIS aquí a mi curso: Ser Más Feliz.  ♥️ Únete a mi membresía TENERTE A TI MISMA para aprender a sanar tu relación contigo y reconstruir tu autoestima: https://tenerteatimismo.com/

Acabamos de publicar el Sermón de la Semana: ¿Por qué necesitamos nuestra iglesia local?. En este mensaje, vemos por qué es tan importante nuestra iglesia local. Es la tierra en la cual crecen nuestras raíces profundas en Dios.. ¡Usálo en tu ministerio! En www.PazConDios.com puedes conseguir el bosquejo detallado de este mensaje para poder usarlo en tu iglesia. También, en esta página hay muchísimos recursos para líderes de la iglesia, y todo completamente gratis.En www.PazConDios.com nuestra misión es equipar a los santos para hacer la obra del ministerio.¡Todo es completamente gratis!Libros: http://pazcondios.com/?page_id=5095Sermones: http://pazcondios.com/?cat=23Seminarios: http://pazcondios.com/?page_id=5121Artículos: http://pazcondios.com/?cat=144¿Preguntas?: preguntas@pazcondios.com¿Consultas del liderazgo?: consejos@pazcondios.comMúsica de PazConDios: https://www.youtube.com/@pazcondiosmusicaTodos los videos: https://www.youtube.com/watch?v=RUF3Gp6FTm0&list=UULFMPaf3L9StVNggFJD7O-KCwTalleres para Líderes: https://www.youtube.com/watch?v=Adol5569wjY&list=PLxsoGHoYj9T8Zle1xyiwD2-SeCudWNOj_Preguntas cortas: https://www.youtube.com/watch?v=RUF3Gp6FTm0&list=PLxsoGHoYj9T-28D2co2gJmEJOMLVvXyNGSermones: https://www.youtube.com/watch?v=JshB0JRyjxM&list=PLxsoGHoYj9T8PubRdWl8jUjqNvR0YNzpjPreguntas y Respuestas EN VIVO: https://www.youtube.com/watch?v=mYgWrC3GTyw&list=PLxsoGHoYj9T-1JqRpVgXRcWTsap8aVLgjEn www.PazConDios.com, proveemos recursos para líderes en la iglesia. Nuestra misión es equipar a los santos para hacer la obra del ministerio. Visítanos en www.PazConDios.com para encontrar toda clase de recursos para líderes completamente gratis.

"Nuestro Señor Jesucristo en esta parte del Sermón del Monte va a seguir usando mandamientos y pasajes del antiguo testamento para dar una correcta enseñanza e interpretación del texto en contraste a lo que decían los escribas y fariseos, como hemos visto antes los escribas y fariseos eran los lideres religiosos de Israel que mas predominaban en la nación. Estos hombres habían enseñado al pueblo a guardar los mandamientos de la ley de una forma muy superficial sin llegar al alcance real del mandato que era llegar al corazón. Como ya vimos estos hombres enseñaban que el mandamiento de: no matarás, se violentaba únicamente con el acto mismo del asesinato, pero Jesús dijo: que cualquiera que llame necio o fatuo (literalmente cabeza hueca) a su hermano ya es culpable de juicio. Luego Jesús también habló sobre el tema del adulterio y expuso lo que enseñaban estos rabinos, que enseñaban que cometer adulterio era solo cometer el acto de acostarse con otra mujer que no sea su esposa, pero Jesús enseña el verdadero adulterio y dice: cualquiera que mire a una mujer con codicia ya adulteró con ella en su corazón. Y así también lo mismo con el divorcio, los rabinos enseñaban que se podía repudiar a la mujer por cualquier causa, pero Jesús enseñó que la única causa de divorcio era por adulterio. Después de hablar sobre asesinato, adulterio y divorcio, temas muy sensibles y fuertes en la sociedad, Jesús ahora dirige su sermón a un tema que también era muy común en la sociedad judía: los juramentos. Lo primero que veremos antes de entrar directamente al texto es la definición de dos palabras que aparecen en este pasaje, para poder entender la enseñanza de Cristo tenemos que comprender primeramente lo que es un juramento y en segundo lugar tenemos que definir lo que es un perjurio." Hermano Jesús Bohórquez.

Sermón: Proverbios (Exposición 5) Serie: Verano en Los Proverbios 2025

Do jornalismo para a apresentação de programas, Sara Sousa Pinto partilha o que aprendeu ao arriscar e ao sair da zona de conforto: na carreira, na sua saída da TVI e muito brevemente enquanto mãe.See omnystudio.com/listener for privacy information.

Sermão ministrado pelo Rev. Luciano Vieira com base em João 4.1-18. Igreja Presbiteriana Redenção.

Sermão ministrado pelo Sem. Luis Felipe Heringer com base em 2 Pedro 3.14-16. Igreja Presbiteriana Redenção.

Diego Manrique acaba de publicar "El mejor oficio del mundo" en el que cuenta su vida como periodista musical, su relación y sus entrevistas con grandes cantantes nacionales e internacionales

Diego Manrique acaba de publicar "El mejor oficio del mundo" en el que cuenta su vida como periodista musical, su relación y sus entrevistas con grandes cantantes nacionales e internacionales

El espacio de deportes en SER Málaga de la Cadena SER

Sermão de domingo (22/06/25), 12º Domingo do Tempo Comum. Texto base se encontra em Salmo 42.Nesse sermão aprendemos que nossa vida é cheia de incertezas, por mais que tentemos controlar nosso destino. Não é porque somos cristãos há muito tempo que não podemos ter dúvidas. Diante das dúvidas, precisamos pregar o Evangelho para nós mesmos. Não é pecado abrirmos nosso coração para Deus, por isso, devemos descansar nossas dúvidas em Deus. Coleta pós sermão: Ó Deus Pai, que lançou a pior onda em seu próprio Filho por amor a nós, nos faça repousar as dúvidas e incertezas em Ti. Confesso que não tenho me dedicado como deveria, as dúvidas me assombram de noite e de dia, não tenho sentido o calor do Teu Evangelho ardendo em meu coração. Torna a dar-me a alegria da Tua salvação e que eu possa, dessa forma, descansar minha alma no Senhor. Por Jesus Cristo, nosso Senhor que intercede por nós. Amém.

El espacio de deportes en SER Málaga de la Cadena SER

✨ Apoya nuestro podcast y disfruta sin interrupciones ✨ Si valoras nuestro contenido, ayúdanos a seguir creando más episodios y, como agradecimiento, escucha Estoicismo Filosofía Premium sin anuncios.

El espacio de deportes en SER Málaga de la Cadena SER

Mensagem gravada em 22/06/2025Pastor Rodrigo FreitasVivendo para cumprir o chamado de Deus Efésios 4:1-16 NVI[1] Como prisioneiro no Senhor, rogo-lhes que vivam de maneira digna da vocação que receberam. [2] Sejam completamente humildes e dóceis, e sejam pacientes, suportando uns aos outros com amor. [3] Façam todo o esforço para conservar a unidade do Espírito pelo vínculo da paz. [4] Há um só corpo e um só Espírito, assim como a esperança para a qual vocês foram chamados é uma só; [5] há um só Senhor, uma só fé, um só batismo, [6] um só Deus e Pai de todos, que é sobre todos, por meio de todos e em todos. [7] E a cada um de nós foi concedida a graça, conforme a medida repartida por Cristo. [8] Por isso é que foi dito: “Quando ele subiu em triunfo às alturas, levou cativos muitos prisioneiros, e deu dons aos homens”. [9] (Que significa “ele subiu”, senão que também havia descido às profundezas da terra? [10] Aquele que desceu é o mesmo que subiu acima de todos os céus, a fim de encher todas as coisas.) [11] E ele designou alguns para apóstolos, outros para profetas, outros para evangelistas, e outros para pastores e mestres, [12] com o fim de preparar os santos para a obra do ministério, para que o corpo de Cristo seja edificado, [13] até que todos alcancemos a unidade da fé e do conhecimento do Filho de Deus, e cheguemos à maturidade, atingindo a medida da plenitude de Cristo. [14] O propósito é que não sejamos mais como crianças, levados de um lado para outro pelas ondas, nem jogados para cá e para lá por todo vento de doutrina e pela astúcia e esperteza de homens que induzem ao erro. [15] Antes, seguindo a verdade em amor, cresçamos em tudo naquele que é a cabeça, Cristo. [16] Dele todo o corpo, ajustado e unido pelo auxílio de todas as juntas, cresce e edifica-se a si mesmo em amor, na medida em que cada parte realiza a sua função.https://bible.com/bible/129/eph.4.1-16.NVI #Jesus #igreja #honra #transformação #Jesus #ressurreição #PalavraDeDeus #DeusPai #EspiritoSanto #PAI #Mensagem #Pregação #Sermão #p4 #p4church #onLine --Curta, compartilhe e inscreva-se para ficar atualizado com os nossos conteúdos!Para saber mais sobre nossa igreja:Site: https://igrejaprojeto4.com.br/Faça seu pedido de Oração: https://igrejaprojeto4.com.br/pedidosFacebook: https://www.facebook.com/p4church/Instagram:  https://www.instagram.com/igrejaprojeto4/Podcast:  https://igrejaprojeto4.com.br/p4cast/Youtube:  [https://www.youtube.com/@IgrejaProjeto4](https://www.youtube.com/IgrejaProjeto4)- --Culto online todos os domingos no YouTube!

Acabamos de publicar el Sermón de la Semana: Trabajar con Jesús crea raíces profundas. En este mensaje, aprendemos cómo desarrollar raíces profundas por trabajar con Jesús.. ¡Usálo en tu ministerio! En www.PazConDios.com puedes conseguir el bosquejo detallado de este mensaje para poder usarlo en tu iglesia. También, en esta página hay muchísimos recursos para líderes de la iglesia, y todo completamente gratis.En www.PazConDios.com nuestra misión es equipar a los santos para hacer la obra del ministerio.¡Todo es completamente gratis!Libros: http://pazcondios.com/?page_id=5095Sermones: http://pazcondios.com/?cat=23Seminarios: http://pazcondios.com/?page_id=5121Artículos: http://pazcondios.com/?cat=144¿Preguntas?: preguntas@pazcondios.com¿Consultas del liderazgo?: consejos@pazcondios.comMúsica de PazConDios: https://www.youtube.com/@pazcondiosmusicaTodos los videos: https://www.youtube.com/watch?v=RUF3Gp6FTm0&list=UULFMPaf3L9StVNggFJD7O-KCwTalleres para Líderes: https://www.youtube.com/watch?v=Adol5569wjY&list=PLxsoGHoYj9T8Zle1xyiwD2-SeCudWNOj_Preguntas cortas: https://www.youtube.com/watch?v=RUF3Gp6FTm0&list=PLxsoGHoYj9T-28D2co2gJmEJOMLVvXyNGSermones: https://www.youtube.com/watch?v=JshB0JRyjxM&list=PLxsoGHoYj9T8PubRdWl8jUjqNvR0YNzpjPreguntas y Respuestas EN VIVO: https://www.youtube.com/watch?v=mYgWrC3GTyw&list=PLxsoGHoYj9T-1JqRpVgXRcWTsap8aVLgjEn www.PazConDios.com, proveemos recursos para líderes en la iglesia. Nuestra misión es equipar a los santos para hacer la obra del ministerio. Visítanos en www.PazConDios.com para encontrar toda clase de recursos para líderes completamente gratis.

Sermón: Proverbios (Exposición 4) Serie: Verano en proverbios Pastor Xavier Torrado

Sermón: Proverbios (Exposición 3) Serie: Verano en proverbios Pastor Felix Colón

Sermón: Proverbios (Exposición 2) Serie: Verano en proverbios Pastor Joel Meléndez

Sermón: Proverbios (Exposición 1) Serie: Verano en proverbios Pastor Xavier Torrado

Sermón: Mateo 21:23-46 Serie: Reinos Enfrentados Pastor Joel Meléndez

Sermón: Mateo 21:1-22 Serie: Reinos Enfrentados Pastor Xavier Torrado

Sermón: Mateo 20:17-34 Serie: Reinos Enfrentados Pastor Joel Meléndez

¿Sientes que nunca es suficiente? ¿Que necesitas demostrar, agradar o esforzarte para sentirte válida? En este episodio hablamos de una herida profunda y común: la de buscar validación externa para sentir que vales. Descubre por qué ocurre, cómo impacta en tu vida y qué pasos puedes dar para dejar de mendigar aprobación y empezar a validarte a ti misma. ⭐ Accede GRATIS aquí a mi curso: Ser Más Feliz.  ♥️ Únete a mi membresía TENERTE A TI MISMA para aprender a sanar tu relación contigo y reconstruir tu autoestima: https://tenerteatimismo.com/

Canal oficial da Igreja Presbiteriana do Brasil em Irajá. Igreja cristã, reformada e com o intuito de glorificar o nome de Jesus Cristo. Venha nos visitar e participar de uma reunião conosco. Estamos nas redes sociais com o @presbiterianadeiraja.Sermão: Rev. Carlos Alberto Monteiro - Culto matutino - 22/06/2025

Canal oficial da Igreja Presbiteriana do Brasil em Irajá. Igreja cristã, reformada e com o intuito de glorificar o nome de Jesus Cristo. Venha nos visitar e participar de uma reunião conosco. Estamos nas redes sociais com o @presbiterianadeiraja.Sermão: Rev. Carlos Alberto Monteiro - Culto vespertino - 22/06/2025

(Estudio del evangelio de Lucas, lección 28) Es fácil caer en la tentación de proyectar una imagen diferente de quien realmente somos. Sin embargo, cuando Jesús predicó en el Sermón del Monte, él reveló el verdadero carácter de quienes le siguen, dejando al descubierto la condición real de nuestro corazón. Jesús nos llama a examinarnos con honestidad y reflejar ciertas características que deben marcar a sus seguidores. Pasaje Bíblico: Lucas 6:38-45

Francisco Rossi, director del Invima, aseguró en La W que la entidad busca avanzar hacia una “regulación procompetitiva para el siglo XXI”.

Acabamos de publicar el Sermón de la Semana: Cómo luchar contra nuestro pecado. En este mensaje, vemos cómo luchar contra nuestro pecado. Y también aprendemos que las raíces profundas vienen por hacer precisamente esto.. ¡Usálo en tu ministerio! En www.PazConDios.com puedes conseguir el bosquejo detallado de este mensaje para poder usarlo en tu iglesia. También, en esta página hay muchísimos recursos para líderes de la iglesia, y todo completamente gratis.En www.PazConDios.com nuestra misión es equipar a los santos para hacer la obra del ministerio.¡Todo es completamente gratis!Libros: http://pazcondios.com/?page_id=5095Sermones: http://pazcondios.com/?cat=23Seminarios: http://pazcondios.com/?page_id=5121Artículos: http://pazcondios.com/?cat=144¿Preguntas?: preguntas@pazcondios.com¿Consultas del liderazgo?: consejos@pazcondios.comMúsica de PazConDios: https://www.youtube.com/@pazcondiosmusicaTodos los videos: https://www.youtube.com/watch?v=RUF3Gp6FTm0&list=UULFMPaf3L9StVNggFJD7O-KCwTalleres para Líderes: https://www.youtube.com/watch?v=Adol5569wjY&list=PLxsoGHoYj9T8Zle1xyiwD2-SeCudWNOj_Preguntas cortas: https://www.youtube.com/watch?v=RUF3Gp6FTm0&list=PLxsoGHoYj9T-28D2co2gJmEJOMLVvXyNGSermones: https://www.youtube.com/watch?v=JshB0JRyjxM&list=PLxsoGHoYj9T8PubRdWl8jUjqNvR0YNzpjPreguntas y Respuestas EN VIVO: https://www.youtube.com/watch?v=mYgWrC3GTyw&list=PLxsoGHoYj9T-1JqRpVgXRcWTsap8aVLgjEn www.PazConDios.com, proveemos recursos para líderes en la iglesia. Nuestra misión es equipar a los santos para hacer la obra del ministerio. Visítanos en www.PazConDios.com para encontrar toda clase de recursos para líderes completamente gratis.

Las bienaventuranzas son las enseñanzas que Jesús nos dio en el Sermón de la Montaña, éstas nos muestran el camino a la felicidad. Y el día de hoy aprenderemos la que dice "bienaventurados los que lloran" para entender mejor el sufrimiento y dolor en nuestras vidas. ¡Quédate con nosotros aquí en Enamórate con Lupita Venegas y aprendamos juntos esta gran enseñanza!

Canal oficial da Igreja Presbiteriana do Brasil em Irajá. Igreja cristã, reformada e com o intuito de glorificar o nome de Jesus Cristo. Venha nos visitar e participar de uma reunião conosco. Estamos nas redes sociais com o @presbiterianadeiraja.Sermão: Rev. Carlos Alberto Monteiro - Culto matutino - 15/06/2025

Canal oficial da Igreja Presbiteriana do Brasil em Irajá. Igreja cristã, reformada e com o intuito de glorificar o nome de Jesus Cristo. Venha nos visitar e participar de uma reunião conosco. Estamos nas redes sociais com o @presbiterianadeiraja.Sermão: Rev. Carlos Alberto Monteiro - Culto noturno - 15/06/2025

====================================================SUSCRIBETEhttps://www.youtube.com/channel/UCNpffyr-7_zP1x1lS89ByaQ?sub_confirmation=1====================================================DEVOCIÓN MATUTINA PARA ADULTOS 2025“CON JESÚS HOY”Narrado por: Exyomara AvilaDesde: Bogotá, ColombiaUna cortesía de DR'Ministries y Canaan Seventh-Day Adventist Church ===================|| www.drministries.org ||===================16 de JunioPacificadores«Bienaventurados los pacificadores, porque serán llamados hijos de Dios» (Mat. 5: 9).En el Sermón del Monte Jesús se presenta como el gran apóstol de la no violencia, es decir, de su plan divino para que aprendamos a convivir felices y libres en un mundo en paz:

Saber lo que necesitas no sirve de nada si no te atreves a decirlo. En este episodio hablamos de cómo dar ese paso que tanto cuesta: expresar lo que sientes, poner tus límites y hacerte valer sin miedo a incomodar. Si siempre te adaptas, si callas para no molestar o te cuesta pedir sin culpa, este episodio es para ti. Porque ser asertiva no es ser borde: es respetarte. Y hablar desde ti —aunque tiemble la voz— es el principio de tu libertad emocional. ⭐ Accede GRATIS aquí a mi curso: Ser Más Feliz.  ♥️ Únete a mi membresía TENERTE A TI MISMA para aprender a sanar tu relación contigo y reconstruir tu autoestima: https://tenerteatimismo.com/

Read OnlineIf your right eye causes you to sin, tear it out and throw it away. It is better for you to lose one of your members than to have your whole body thrown into Gehenna. And if your right hand causes you to sin, cut it off and throw it away. It is better for you to lose one of your members than to have your whole body go into Gehenna. Matthew 5:29–30This imagery of tearing out your eye and cutting off your hand is clearly meant to get our attention. Though we can be certain that Jesus is not actually suggesting we mutilate our bodies, we should not hesitate to prayerfully ponder this imagery so as to understand the truths Jesus is speaking.Saint Augustine, in reflecting upon this passage, states: “By the eye we must understand our most cherished friend…” Augustine further points out that Jesus specifically mentions the “right eye” as a way of denoting those friendships that have a “higher degree of affection” (Serm. in Mont. i. 13.). Thus, although friendship—especially very close friendship—is a gift, sometimes those close to us can become a source of sin or an occasion of sin. In that case, they are not truly friends, and it might be better to limit or even end that relationship rather than to allow it to lead us into sin.Think about the people in your own life. Though we must love all people with the love of God, friendship is more than love. Friendship establishes a special bond with another and opens you up to their presence and influence in your life. When you establish a friendship, you allow another a certain influence in your life. When that influence is good, then the friendship produces much good fruit. But when that influence is evil, then that friendship becomes a danger to the good of your soul. In that case, it may need to be torn out or cut off so that you are not drawn into serious sin or even the occasion of sin.When a friend in your life becomes an occasion of sin to you, your love for them must remain, but it must also change. Love, in this case, may take on the form of a loving rebuke, a withdrawal of your own heart, or a limiting of your interactions. But this is love. By analogy, when a person sins against God, their relationship with God also changes. God withdraws His friendship. He is less present to the person, and their internal communion diminishes or even ends when the sin is serious. This is not a lack of love on God's part; it is simply the effect of sin. So also in our relations with another, when the grace of God is not mutually given and received between two people, then friendship in the truest sense is not possible. True friendship is always centered in God's grace and dependent upon it. Therefore, when God is excluded from a relationship, that relationship must change from a true friendship to a relationship that imitates God's love for a sinner. Mercy, compassion and forgiveness must continually be offered, but interior communion and unity will end. But this is love.Reflect, today, upon those in your life whom God has given you to love. First, reflect upon those relationships that do have God at the center. These relationships will become true friendships and will produce an abundance of good fruit in your life. Rejoice in these friendships and give thanks to God for them. Second, reflect upon any relationship that does not bear good fruit. As you do, prayerfully consider how you approach that relationship. Do you attempt to maintain a “friendship” even though God is not able to be the center of that relationship? If so, ponder how God is calling you to change that relationship so that it more fully reflects the love God has for you and for that other person in your life.My Lord and true Friend, I thank You for loving me with a perfect love. I pray that I will always be open to that love so that my unity with You will ever deepen. I also pray that I will be an instrument of Your love to others. Please give me the grace to love everyone in my life in the way that You love them, nothing less and nothing more. Jesus, I trust in You.Image:  El Salvador beneint by Lluís Ribes Mateu, license CC BY-NC 2.0Source of content: catholic-daily-reflections.comCopyright © 2025 My Catholic Life! Inc. All rights reserved. Used with permission via RSS feed.

¿Sientes que no puedes pasar página, aunque haya pasado el tiempo? ¿Sigues dándole vueltas a lo que te hicieron, como si revivieras una y otra vez la misma escena? En este episodio te hablo de por qué cuesta tanto soltar el resentimiento, qué función inconsciente cumple en tu vida y cómo liberarte de esa carga sin traicionarte a ti misma. No se trata de justificar al otro ni de reconciliarte con nadie. Se trata de recuperar tu paz, tu energía y tu capacidad de abrirte de nuevo a la vida. ⭐ Accede GRATIS aquí a mi curso: Ser Más Feliz.  ♥️ Únete a mi membresía TENERTE A TI MISMA para aprender a sanar tu relación contigo y reconstruir tu autoestima: https://tenerteatimismo.com/

Canal oficial da Igreja Presbiteriana do Brasil em Irajá. Igreja cristã, reformada e com o intuito de glorificar o nome de Jesus Cristo. Venha nos visitar e participar de uma reunião conosco. Estamos nas redes sociais com o @presbiterianadeiraja.Sermão: Rev. Carlos Alberto Monteiro - Culto matutino - 08/06/2025

Canal oficial da Igreja Presbiteriana do Brasil em Irajá. Igreja cristã, reformada e com o intuito de glorificar o nome de Jesus Cristo. Venha nos visitar e participar de uma reunião conosco. Estamos nas redes sociais com o @presbiterianadeiraja.Sermão: Sem. Wellerson Samuel - Culto noturno - 09/06/2025

Neste episódio, Vanda (nome fictício) me escreve, irritada com uma fala minha em que eu disse que estava amando ser pai de adolescente. Eu respondo ao bilhete dela com uma conversa sobre o diálogo possível com eles, e sobre como nós, culturamente, andamos muito mal na forma de reconhecer a beleza possível que eles trazem para o mundo. Então dê o play e venha para mais um CARTAS DE UM TERAPEUTA!As cartas são a escrita que a alma faz, sem rodeios, para as perguntas que nos inquietam, para aquilo que nos atravessa, para a vida que tem urgência de ser dita. Em palavras faladas, as cartas são o sopro que nos conecta por um instante. Abra este envelope, ele é pra você. Vai começar mais um episódio do “Cartas de um terapeuta”.Cartas de um Terapeuta é um podcast apresentado por Alexandre Coimbra Amaral.E para enviar a sua carta o e-mail é: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠alexandrecoimbraamaral@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Produzido por Abrace Podcasts. Visite-nos em ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://abrace.digital/⁠⁠⁠⁠⁠⁠⁠⁠Esta temporada é apresentada por Avatim. Acesse o link ⁠⁠⁠https://bit.ly/cartas-e-avatim⁠⁠⁠ e use o cupom CARTAS15 para garantir 15% de desconto em todos os produtos do site.

Resumen de noticias de la mañana de LA NACION del 3 de junio de 2025 

El análisis de actualidad económica, todas las mañanas a las 07:30. 

Hablar en público no es lucirseEl objetivo principal de hablar en público no es ser brillante. Ni ser gracioso. Ni parecer interesante. Hablar en público se trata de servir. Y eso cambia todo. Te explico.Hablar en público no es lucirse, es servir¿Te da susto hablar en público? Bueno, es normal. A la mayoría nos ha pasado. El problema es que creemos que estamos ahí para demostrar algo: inteligencia, carisma, talento. Cuando en realidad estamos ahí para otra cosa.Estamos ahí para ayudar.Hablar en público es, ante todo, un acto de servicio. Es compartir algo que puede hacerle bien a otro. Una idea, una historia, un dato. Un punto de vista. Un chiste, incluso. No para que se rían de ti, sino para que se rían contigo.Cuando dejas de pensar en “lucirte” y empiezas a pensar en “servir”, algo se desbloquea. Ya no es tu ego el que está en juego. Es tu mensaje. Es lo que puedes dejarle al otro. Y ahí, mágicamente, baja el miedo.¿Cómo se ve eso en la práctica?– No memorices discursos, entiende el mensaje que quieres dejar.– No hables como experto, habla como alguien que quiere ayudar.– No esperes aplausos, espera conexión.– No temas equivocarte, teme no aportar.Una vez un conocido dio una charla con la camisa algo arrugada. Era una tela delicada y probablemente el ajetreo previo y el haberse sentado en algún sofá, se la desorganizaron un poco. Al principio se sintió fatal. Después, se concentró en el tema. Nadie mencionó la camisa. Pero sí le escribieron varios para agradecerle el contenido. Y ahí el y yo entendimos: el orador no era el protagonista. Era el mensaje.Si vas a hablar en público, piensa a quién puedes servir con eso que sabes o que has vivido. Porque no se trata de parecer brillante, sino de ser útil.En este episodio te comparto algunas historias de sacerdotes que se quieren lucir en su sermón, y su palabra no impacta. No es que este sea un episodio religioso ni mucho menos.#Hablar en público, #Oratoria, #Comunicación efectiva, #Miedo escénico, #Servicio al comunicar, #Santiago Ríos, #Mil Palabras, #Marca personal, #Storytelling, #Habilidades blandas, #Presentaciones, #Podcast, #Podcast Corporativo, #Sermón, #Cura, #Misa, #SacerdoteRecuerda por favor escucharnos y suscribirte en la plataforma que más te guste:https://podcasts.apple.com/co/podcast/mil-palabras/id1472769024 https://open.spotify.com/show/4ntUNh1i9rPue1MkeuEYLs http://bit.ly/googleMPhttps://www.spreaker.com/podcast/mil-palabras--4898895https://www.deezer.com/mx/show/1872052Para participar, escríbeme tus comentarios a santiagorios@milpalabras.com.coRecursos recomendados en este PodcastSuscríbete al http://www.milpalabras.com enhttp://www.milpalabras.comDescarga GRATIS el ebook “Cómo Crear un Podcast Corporativo”https://milpalabras.com.co/Otros podcasts recomendados de nuestra redUn café con tu futuroLas mejores prácticas empresariales para crecer como profesional y como persona.

En Ivoox puedes encontrar sólo algunos de los audios de Mindalia. Para escuchar las 4 grabaciones diarias que publicamos entra en https://www.mindaliatelevision.com. Si deseas ver el vídeo perteneciente a este audio, pincha aquí: https://www.youtube.com/watch?v=l8e3kbH2xEU ¿Es posible comunicarse con los que han partido? ¿Tienes señales, sueños o intuiciones y no sabes qué significan? Raúl Vaquero, médium, revela cómo funciona la conexión con el más allá y si cualquier persona puede desarrollar esta capacidad. Descubre los secretos de la mediumnidad y aprende a interpretar los mensajes del otro lado. ¡No es casualidad que estés aquí! Raúl Vaquero Médium Médium mundialmente reconocido. Más información en: https://www.mindalia.com/television/ PARTICIPA CON TUS COMENTARIOS EN ESTE VÍDEO. -----------INFORMACIÓN SOBRE MINDALIA--------- Mindalia.com es una ONG internacional, sin ánimo de lucro, que difunde universalmente contenidos sobre espiritualidad y bienestar para la mejora de la consciencia del mundo. Apóyanos con tu donación en: https://www.mindalia.com/donar/ Suscríbete, comenta positivamente y comparte nuestros vídeos para difundir este conocimiento a miles de personas. Nuestro sitio web: https://www.mindalia.com SÍGUENOS TAMBIÉN EN NUESTRAS PLATAFORMAS Facebook: / mindalia.ayuda Instagram: / mindalia_com Twitch: / mindaliacom Odysee: https://odysee.com/@Mindalia.com *Mindalia.com no se hace responsable de las opiniones vertidas en este vídeo, ni necesariamente participa de ellas.

¿Sientes que la vida te está hablando pero no sabes cómo escucharla? En este episodio hablamos de espiritualidad sin dogmas, de sincronicidades como lenguaje simbólico y de cómo desarrollar una conexión directa con la vida que te dé sentido, pertenencia y dirección, especialmente en los momentos más difíciles. ⭐ Accede GRATIS aquí a mi curso: Ser Más Feliz. ❤️‍

Dr. John Sweetenham and Dr. Erika Hamilton discuss top abstracts that will be presented at the 2025 ASCO Annual Meeting, including research on tech innovations that could shape the future of oncology. Transcript Dr. John Sweetenham: Hello, and welcome to the ASCO Daily News Podcast. I'm your host, Dr. John Sweetenham, and I'm delighted to be joined today by Dr. Erika Hamilton, a medical oncologist and director of breast cancer and gynecologic cancer research at the Sarah Cannon Research Institute in Nashville, Tennessee. Dr. Hamilton is also the chair of the 2025 ASCO Annual Meeting Scientific Program, and she's here to tell us about some of the key abstracts, hot topics, and novel approaches in cancer care that will be featured at this year's Annual Meeting. Our full disclosures are available in the transcript of this episode. Dr. Hamilton, it's great to have you on the podcast today, and thanks so much for being here. Dr. Erika Hamilton: Thanks, Dr. Sweetenham. I'm glad to be here. Dr. John Sweetenham: Dr. Hamilton, the Presidential Theme of the Annual Meeting this year is ‘Driving Knowledge to Action: Building a Better Future,' and that's reflected in many of the sessions that will focus on action-oriented guidance to improve care for our patients. And as always, there'll be great presentations on practice-changing abstracts that will change treatment paradigms and transform care. Can you tell us about some of the hot topics this year and what you're particularly excited about? Dr. Erika Hamilton: You're right. Dr. Robin Zon's theme is ‘Driving Knowledge to Action: Building a Better Future,' and you're going to see that theme really interlaced throughout the ASCO program this year. We had a record number of submissions. Over 5,000 abstracts will be published, and there'll be about 3,000 presentations, either in oral format or poster presentations. We have 200 dynamic sessions. Many of the discussants will be highlighting key takeaways and how we can translate action-oriented guidance to better treat our patients to build a better future. Our state-of-the-art science will include a Plenary Session. This will feature presentations as well as discussion of each of the presentations for clinical late-breaking abstracts. We have Clinical Science Symposia that I'm particularly excited about this year. These will feature key abstracts as well as discussions and a foundational talk around the subject. We're covering novel antibody-drug conjugate targets, turning “cold” tumors “hot” to include CAR T, as well as the future of cancer detection. There'll be rapid oral abstracts, case-based panels, and this will also feature interactive audience polling and case discussions. I also want to highlight the community connection opportunities. There will be 13 Communities of Practice that will be meeting on-site during ASCO, and there's also really a plethora of networking opportunities for trainees and early-career professionals, a Women's Networking Center, a patient advocate space, and I'm happy to report there will also be live music out on the terrace this year at ASCO. Dr. John Sweetenham: Well, that's going to be a really great addition. I have to say, I think this is always a special time of year because excitement starts to mount as the meeting gets closer and closer. And once the abstracts are out there, I certainly personally feel that the excitement builds. Talking of abstracts, let's dive into some of the key abstracts for this year's meeting. I'd like to start out by asking you about Abstract 505. This reports on 15-year outcomes for women with premenopausal hormone receptor-positive early breast cancer in the SOFT and TEXT trials. It assesses the benefits of adjuvant exemestane and ovarian function suppression or tamoxifen and ovarian function suppression. So, could you talk us through this and tell us what you think the key takeaways from this abstract are? Dr. Erika Hamilton: Absolutely. This is essentially the SOFT and TEXT trials. They are trials that we've been following for quite some time, evidenced by the 15-year outcome. And I think it really answers two very important questions for us regarding adjuvant endocrine therapy for patients that are facing hormone receptor-positive disease. The benefit of ovarian function suppression for one, and then second, the benefit of exemestane over tamoxifen, which is our SERM [selective estrogen receptor modulator]. So, in terms of the SOFT trial, when we talk about distance recurrence-free interval, which I really think is probably the most meaningful because secondary cancers, et cetera, are not really what we're getting at here. But in terms of distant recurrence-free interval, certainly with tamoxifen, using tamoxifen plus ovarian function suppression adds a little bit. But where we really get additional benefits are by moving to exemestane, an aromatase inhibitor with the ovarian function suppression. So, for example, in SOFT, for distant recurrence-free interval for patients that have received prior chemotherapy, the distance recurrence-free interval was 73.5% with tamoxifen, bumped up just a tiny bit to 73.8% with ovarian function suppression. But when we used both ovarian function suppression and switched to that aromatase inhibitor, we're now talking about 77.6%. It may seem like these are small numbers, but when we talk about an absolute benefit of 4%, these are the type of decisions that we decide whether to offer chemotherapy based on. So, really just optimizing endocrine therapy really can provide additional benefits for these patients. Just briefly, when we turn to TEXT, similarly, when we look at distance recurrence-free interval for our patients that are at highest risk and receive chemotherapy, tamoxifen and ovarian function suppression, 79%; 81% with exemestane and ovarian function suppression. And when we talk about our patients that did not receive chemotherapy, it increased from 91.6% up to 94.6%—very similar that 3% to 4% number. So, I think that this is just very important information when counseling our patients about the decisions that they're going to make for themselves in the adjuvant setting and how much we want to optimize endocrine therapy. Dr. John Sweetenham: Thanks so much for your insight into that. Dr. Erika Hamilton: Yeah, absolutely. So, let's turn to hematologic malignancies. Abstract 6506 reports exciting results on the new agent ziftomenib in relapsed/refractory NPM1-mutant acute myeloid leukemia. This is a phase 1b clinical activity study and safety results. This was the pivotal KOMET-001 study. And my question is, will this new agent fulfill an unmet need in this NPM1 space? Dr. John Sweetenham: Yeah, great question. And I think the answer is almost certainly ‘yes'. So, just as some brief background, NPM1 mutation is known to be a driver of leukemogenesis in around 30% of patients with AML, and it's a poor prognostic factor. And typically, about 50% of these patients will relapse within a year of their first-line therapy, and only around 10% of them will get a subsequent complete remission with salvage therapy. Menin inhibitors, which disrupt the interaction between menin and KMT2A, are known to be active in NPM1-mutated as well as in KMT2A-rearranged AML. And ziftomenib is a selective oral menin inhibitor, which in this study was evaluated at a dose of 600 mg once a day, as you mentioned, a phase 1b/2 study, which is multicenter and presented by Dr. Eunice Wang from Roswell Park. It's a relatively large study of 112 patients who were treated with this standard dose with relatively short median follow-up at this time. The median age was 69 years, and median prior therapies were two, but with a range of one to seven. And I think very importantly, 60% of these patients had previously been treated with venetoclax, and 23% of them had had a prior transplant. Looking at the results overall for this study, the overall response rate was 35%, which is actually quite impressive. Specifically for those patients in the phase 2 part of the study, around 23% achieved a CR [complete remission] or CRh [complete remission with partial hematologic recovery]. What's very interesting in my mind is that the response rates were comparable in venetoclax-naive and venetoclax-exposed patients. And the drug was very well tolerated, with only 3% of patients having to discontinue because of treatment-related adverse events. And I think the authors appropriately conclude that, first of all, the phase 2 primary endpoint in the study was met, and that ziftomenib achieved deep and durable responses in relapsed and refractory NPM1-mutated AML, regardless of prior venetoclax, with good tolerance of the drug. And so, I think putting all of this together, undoubtedly, these data do support the potential use of this agent as monotherapy and as a new option for those patients who have relapsed or refractory NPM1-mutated acute myeloid leukemia. So, let's move on a little bit more now and change the subject and change gears completely and talk about circulating tumor DNA [ctDNA]. This has been a hot topic over a number of years now, and at this year's meeting, there are quite a few impactful studies on the use of ctDNA. We have time to focus on just one of these, and I wanted to get your thoughts on Abstract 4503. This is from the NIAGARA trial, which looks at ctDNA in patients with muscle-invasive bladder cancer who receive perioperative durvalumab. Could you tell us a little bit about this study? Dr. Erika Hamilton: So, this was the phase 3 NIAGARA trial, and this is literally looking for patients with muscle-invasive bladder cancer that are cisplatin-eligible, and the addition of durvalumab to neoadjuvant chemotherapy. So here, this is a planned exploratory analysis of ctDNA and the association with clinical outcomes from NIAGARA. So, this is really the type of study that helps us determine which of our patients are more likely to have a good outcome and which of our patients are more likely not to. There were 1,000 randomized patients in this study, and 462 comprised the biomarker-evaluable population. There were about half in the control arm and half in the durvalumab arm. And overall, the ctDNA-positive rate at baseline was about 57%, or a little over half, and that had decreased to about 22% after neoadjuvant treatment. ctDNA clearance rates from baseline to pre-radical cystectomy was about 41% among those with durvalumab and 31% among those in control. And the non-pCR rate was 97% among patients with pre-cystectomy ctDNA-positive status. So, this really gives us some information about predicting who is going to have better outcomes here. We did see a disease-free survival benefit with perioperative durvalumab, and this was observed in post-cystectomy ctDNA-positive as well as the ctDNA-negative groups. Shifting gears now to GI cancer, Abstract 3506 is a long-term safety and efficacy study of sotorasib plus panitumumab and FOLFIRI for previously treated KRAS G12C-mutated metastatic colorectal cancer. And this is the CodeBreaK-101 study. What are your thoughts on this study? Dr. John Sweetenham: Yeah, thanks. A very interesting study, and this abstract builds upon the phase 3 CodeBreaK-300 trial, which I think has just been published in the Journal of Clinical Oncology. This showed that the combination of sotorasib and panitumumab improved clinical outcomes in patients with chemorefractory KRAS G12C-mutated metastatic colorectal cancer. The current abstract, as you mentioned, reports the CodeBreaK-101 trial. And this was a phase 1b trial where FOLFIRI therapy was added to sotorasib and panitumumab in previously treated patients with KRAS G12C-mutated metastatic colorectal cancer. The abstract reports the overall and progression-free survival results, as well as some updated safety and response data. So, in this study, patients with this particular mutation who had received at least one prior systemic treatment but were KRAS G12C inhibitor-naive were enrolled into an expansion cohort of the CodeBreaK-101 protocol. And these patients received what apparently now recommended as the standard phase 2 dose of sotorasib of 960 mg daily, plus panitumumab and a standard dose of FOLFIRI. And the primary endpoint of the study was safety, and secondary endpoints included confirmed response, overall response, and progression-free survival, as assessed by the investigator. And by November of last year, 40 patients had been enrolled into this study. Common treatment-related adverse events were cutaneous; some patients developed neutropenia, and stomatitis was fairly widespread. Discontinuation of sotorasib because of adverse events was only seen in 1% of patients, although patients did have to discontinue because of toxicity from some of the other agents in the combination. Looking at the results of this study, the updated objective response rate was 57.5%, and the disease control rate was estimated at 92%, going on 93%, with a median time to response of 1.6 months and a median response duration of 6 months. After a median follow-up of 29.2 months, the median progression-free survival was 8.2 months, and the overall survival 17.9 months. So, the authors have concluded that this combination, including sotorasib, panitumumab, and FOLFIRI, does appear to show quite promising long-term efficacy in pretreated patients with this specific mutation. The ongoing phase 3 study they mentioned, CodeBreaK-301, is aiming to evaluate this combination against the standard of care in the first-line setting for patients with KRAS G12C-mutated colorectal cancer. So, promising results, and we'd be very interested to see how this particular combination performs in the frontline. Dr. Erika Hamilton: Fantastic. Thanks so much for sharing that. Let's shift gears again and really talk about digital technology. I feel that we're all going to have to get much better with this, and really, there are a lot of promises for our patients coming here. There are a lot of abstracts at ASCO that are focusing on innovations in digital technology, including a really interesting psychosocial digital application for caregivers of patients that are undergoing hematopoietic stem cell transplantation. Can you tell us a little bit about this? It's Abstract 11000. Dr. John Sweetenham: Yeah, absolutely. This abstract certainly caught my eye, and I think it's intriguing for a number of reasons, partly because it's app-based, and partly also because it specifically addresses caregiver burden and caregiver needs in the oncology setting, which I think is especially important. And although the context, the clinical context of this study, is hematopoietic stem cell transplantation, I think it has potential applications way beyond that. We all know that caregivers of patients undergoing stem cell transplantation have significant quality-of-life struggles. They are well-documented to have significant psychological and emotional strain before, during, and after stem cell transplantation. And this abstract describes an application called BMT-CARE, which is aimed at improving caregivers' quality of life, caregiver burden, mood symptoms, and coping skills, and so on. So, this was a single-center, randomized trial from MGH [Massachusetts General Hospital] of this app for stem cell transplant caregivers, compared with usual care in those individuals. And the eligible patients, or eligible individuals, were adults caring for patients with heme malignancy undergoing either an autologous or an allogeneic stem cell transplant. Patients were randomly assigned either to use the app or for usual care. And the app itself—and I think it'll be interesting to actually see this at the meeting and visualize it and see how user-friendly and so on it is—but it comprises five modules, which integrate psychoeducation, behavior change, stress management, and they're delivered through a kind of interactive platform of educational games and videos. And then participants were self-reporting at baseline and then 60 days after transplant. So, around 125 patients were enrolled in this study, of around 174 who were initially approached. So, just over 70% uptake from caregivers, which is, I think, relatively high, and evenly distributed between the two randomized arms. And the majority of the participants were spouses. And at 60 days post-stem cell transplant, the intervention participants reported a better quality of life compared with those who received usual care. If you break this down a little bit more, these participants reported lower caregiving burden, lower incidence of depression, fewer PTSD symptoms, and overall better coping skills. So, the authors conclude that this particular app, a digital health intervention, led to pretty substantial improvements in quality of life for these caregivers. So, intriguing. As I said, it'll be particularly interesting to see how this thing looks during the meeting. But if these kind of results can be reproduced, I think this sort of application has potential uses way beyond the stem cell transplant setting. Dr. Erika Hamilton: Yeah, I find that just so fascinating and very needed. I think that the caregiving role is often underestimated in how important that is for the patient and the whole family, and really giving our caregivers more tools in their toolbox certainly is quite helpful. Dr. John Sweetenham: Absolutely. Well, the meeting is getting closer, and as I mentioned earlier, I think anticipation is mounting. And I wanted to say thanks so much to you for chatting with me today about some of the interesting advances in oncology that we're going to see at this year's meeting. There is a great deal more to come. Our listeners can access links to the studies we've discussed today in the transcript of this episode. I'm also looking forward, Dr. Hamilton, to having you back on the podcast after the Annual Meeting to dive into some of the late-breaking abstracts and some of the other key science that's captured the headlines this year. So, thanks once again for joining me today. Dr. Erika Hamilton: Thanks so much for having me. Pleasure. Dr. John Sweetenham: And thank you to our listeners for joining us today. Be sure to catch my “Top Takeaways from ASCO25.” These are short episodes that will drop each day of the meeting at 5:30 p.m. Eastern Time. So, subscribe to the ASCO Daily News Podcast wherever you prefer to listen, and join me for concise analyses of the meeting's key abstracts.   Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.   More on today's speakers: Dr. John Sweetenham   Dr. Erika Hamilton @erikahamilton9   Follow ASCO on social media:  @ASCO on Twitter  ASCO on Bluesky  ASCO on Facebook   ASCO on LinkedIn     Disclosures:     Dr. John Sweetenham:     No relationships to disclose  Dr. Erika Hamilton: Consulting or Advisory Role (Inst): Pfizer, Genentech/Roche, Lilly, Daiichi Sankyo, Mersana, AstraZeneca, Novartis, Ellipses Pharma, Olema Pharmaceuticals, Stemline Therapeutics, Tubulis, Verascity Science, Theratechnologies, Accutar Biotechnology, Entos, Fosun Pharma, Gilead Sciences, Jazz Pharmaceuticals, Medical Pharma Services, Hosun Pharma, Zentalis Pharmaceuticals, Jefferies, Tempus Labs, Arvinas, Circle Pharma, Janssen, Johnson and Johnson   Research Funding (Inst): AstraZeneca, Hutchison MediPharma, OncoMed, MedImmune, Stem CentRx, Genentech/Roche, Curis, Verastem, Zymeworks, Syndax, Lycera, Rgenix, Novartis, Millenium, TapImmune, Inc., Lilly, Pfizer, Lilly, Pfizer, Tesaro, Boehringer Ingelheim, H3 Biomedicine, Radius Health, Acerta Pharma, Macrogenics, Abbvie, Immunomedics, Fujifilm, eFFECTOR Therapeutics, Merus, Nucana, Regeneron, Leap Therapeutics, Taiho Pharmaceuticals, EMD Serono, Daiichi Sankyo, ArQule, Syros Pharmaceuticals, Clovis Oncology, CytomX Therapeutics, InventisBio, Deciphera, Sermonix Pharmaceuticals, Zenith Epigentics, Arvinas, Harpoon, Black Diamond, Orinove, Molecular Templates, Seattle Genetics, Compugen, GI Therapeutics, Karyopharm Therapeutics, Dana-Farber Cancer Hospital, Shattuck Labs, PharmaMar, Olema Pharmaceuticals, Immunogen, Plexxikon, Amgen, Akesobio Australia, ADC Therapeutics, AtlasMedx, Aravive, Ellipses Pharma, Incyte, MabSpace Biosciences, ORIC Pharmaceuticals, Pieris Pharmaceuticals, Pieris Pharmaceuticals, Pionyr, Repetoire Immune Medicines, Treadwell Therapeutics, Accutar Biotech, Artios, Bliss Biopharmaceutical, Cascadian Therapeutics, Dantari, Duality Biologics, Elucida Oncology, Infinity Pharmaceuticals, Relay Therapeutics, Tolmar, Torque, BeiGene, Context Therapeutics, K-Group Beta, Kind Pharmaceuticals, Loxo Oncology, Oncothyreon, Orum Therapeutics, Prelude Therapeutics, Profound Bio, Cullinan Oncology, Bristol-Myers Squib, Eisai, Fochon Pharmaceuticals, Gilead Sciences, Inspirna, Myriad Genetics, Silverback Therapeutics, Stemline Therapeutics

En este mensaje tratamos el siguiente caso de una mujer que «descargó su conciencia» de manera anónima en nuestro sitio www.conciencia.net, autorizándonos a que la citáramos: «Soy una joven de veinticuatro años y vivo con mis padres.... Mi madre... se enojó [mucho porque no logré] ser médica, y me compara con mi hermana menor, quien pudo completar sus estudios antes que yo. »He caído en una depresión por no hacerla feliz con mi carrera y mi vida.... Yo trato de dirigirme a ella con respeto... pero ella no se siente honrada. »Tengo trabajo y sigo asistiendo a la escuela. Le he dicho que quiero mudarme para independizarme, pero ella lo toma a mal y me dice que no me mude sino hasta que me case.» Este es el consejo que le dio mi esposa: «Estimada amiga: »Comprendemos por qué se siente descorazonada. Por lo general, cuando alguna persona a quien amamos está decepcionada de nosotros, eso hace que nos sintamos mal. Esa sensación de deficiencia nos lleva entonces a tener pensamientos recurrentes que ponen en tela de juicio todo lo que creemos acerca de quiénes somos. Y cuando dudamos de nosotros mismos, es muy difícil estar motivados acerca del futuro. »... Es posible que [su mamá] la presione a usted debido a que ella nunca logró lo que quiso en su propia vida y, como resultado, quiere que, a diferencia de ella, usted no tenga que arrepentirse de nada a lo largo de su vida. O tal vez crea que le corresponde a ella como mamá suya ejercer presión cuando usted no obtiene los logros que ella piensa que usted es capaz de alcanzar. »Los padres que tienen hijos adultos deben pasar de ser proveedores, protectores y maestros, a ser amigos cercanos que los animan. Sin embargo, algunos padres nunca llegan a comprender que ese cambio en la relación es saludable. Y otros padres dejan que influyan en ellos su propia inseguridad y personalidad dominante, o su propia inmadurez y egoísmo. »Su mamá concibe que ella la protege al mantenerla en casa hasta que usted se case. Pero ¿qué tal si usted decide no casarse? ... Los hijos adultos que siguen viviendo con los padres a veces descubren que con el paso de los años se vuelve cada vez más difícil independizarse. »Si usted cuenta con los recursos económicos necesarios para vivir por su propia cuenta, entonces creemos que el mudarse e independizarse es una opción aceptable. No obstante, esa decisión la debe tomar conforme a su contexto cultural, ya que algunas culturas no permiten que las mujeres vivan por su propia cuenta. »Usted dice que, a pesar de dirigirse a su mamá con respeto, ella no se siente honrada por usted. Ya que uno de los Diez Mandamientos es honrar a padre y madre, le aconsejamos que siempre honre a su mamá. Sin embargo, honrarla no significa obedecerla o estar de acuerdo con ella en todas las cosas. Ni significa que usted esté obligada a ejercer la profesión que ella desea que practique.» Con eso termina lo que recomienda Linda, mi esposa. El consejo completo puede leerse con sólo ingresar en el sitio www.conciencia.net y pulsar la pestaña que dice: «Casos», y luego buscar el Caso 723. Carlos ReyUn Mensaje a la Concienciawww.conciencia.net